scispace - formally typeset
Y

Yijin Wang

Researcher at Chinese PLA General Hospital

Publications -  58
Citations -  9078

Yijin Wang is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Hepatitis E virus & Hepatitis E. The author has an hindex of 21, co-authored 56 publications receiving 6759 citations. Previous affiliations of Yijin Wang include Southern University of Science and Technology & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.

TL;DR: The liver enzyme abnormality was associated with disease severity, as well as a series of laboratory tests including higher A-aDO2, higher GGT, lower albumin, decreased CD4+ T cells and B lymphocytes, and histologically, massive hepatic apoptosis and a certain binuclear hepatocytes were observed.
Journal ArticleDOI

Clinical and pathological investigation of patients with severe COVID-19.

TL;DR: Circulating cytokines, including IL-8, IL-6, TNF-α, IP10, MCP1, and RANTES, were significantly elevated in patients with severe COVID-19 and could be used to predict disease deterioration and inform clinical interventions.
Journal ArticleDOI

Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E Virus

TL;DR: These findings should be considered when physicians select immunosuppressive therapies for recipients of organ transplants who are infected with HEV, and the combination of MPA and ribavirin had a greater ability to inhibit HEV replication than MPA or ribavirus alone.
Journal ArticleDOI

Modeling rotavirus infection and antiviral therapy using primary intestinal organoids.

TL;DR: Human organoids efficiently support the infection of patient-derived rotavirus strains and can be potentially harnessed for personalized evaluation of the efficacy of antiviral medications, providing a robust model system for studying rotav virus-host interactions and assessing antiviral medicines.